Evidence map›Paper›PMID 32586903›Full record

ArticleHaematologica2021

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma.

Keiichiro Watanabe, Ariunzaya Bat-Erdene, Hirofumi Tenshin, Qu Cui, Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Takeshi Harada, Hirokazu Miki, Kimiko Sogabe and 9 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Chemical biology research in RIKEN NPDepo aimed at agricultural applications.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2025
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Keiichiro WatanabeInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Ariunzaya Bat-ErdeneSchool of Bio-Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Hirofumi TenshinInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Qu CuiDept. of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jumpei TeramachiDepartment of Tissue Regeneration, Tokushima University Graduate School, Japan.
Masahiro HiasaThe University of Tokushima Graduate School of Oral Science, Tokushima, Japan.
Asuka OdaInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Takeshi HaradaInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Hirokazu MikiDiv of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan.
Kimiko SogabeInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Masahiro OuraInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Ryohei SumitaniInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Yukari MitsuiInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Itsuro EndoInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Eiji TanakaThe University of Tokushima Graduate School of Oral Science, Tokushima, Japan.
Makoto KawataniRIKEN Center for Sustainable Resource Science, Chemical Biology Research Group, Saitama, Japan.
Hiroyuki OsadaRIKEN Center for Sustainable Resource Science, Chemical Biology Research Group, Saitama, Japan.
Toshio MatsumotoFujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan.
Masahiro AbeInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Tokushima University · JPRIKEN Center for Sustainable Resource Science · JPBeijing Tian Tan Hospital · CNMongolian National University of Medical Sciences · MNTokushima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaOsteolysisSpiro CompoundsHumansOsteoclastsPyransPyransreveromycin ASpiro Compounds

Identifiers

PMID32586903
PMCPMC8018113
OpenAlexW3037833576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.